Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)

China flag China · Delayed Price · Currency is CNY
60.66
-1.64 (-2.63%)
Sep 26, 2025, 3:04 PM CST
-2.63%
Market Cap67.62B
Revenue (ttm)4.10B
Net Income (ttm)622.56M
Shares Out1.11B
EPS (ttm)0.56
PE Ratio108.37
Forward PE99.44
Dividend0.50 (0.82%)
Ex-Dividend DateMay 14, 2025
Volume9,077,920
Average Volume10,594,282
Open62.28
Previous Close62.30
Day's Range60.40 - 62.28
52-Week Range27.66 - 65.63
Beta0.45
RSI64.82
Earnings DateOct 24, 2025

About SHE:002294

Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of medicines and medical devices in China. The company offers drugs for various therapeutic fields, such as thrombosis, hypertension and related diseases, osteoporosis, and infections, as well as anti-osteolysis, antiallergic, antiepileptic, and antidepressant medicines. It also provides interventional medical devices for therapy of cardiovascular and cerebrovascular diseases, peripheral blood vessels, structural heart diseases, electrophysiol... [Read more]

Sector Healthcare
Founded 1998
Employees 3,596
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002294
Full Company Profile

Financial Performance

In 2024, SHE:002294's revenue was 4.01 billion, an increase of 19.22% compared to the previous year's 3.37 billion. Earnings were 601.57 million, an increase of 3.71%.

Financial Statements

News

There is no news available yet.